Trypanosoma brucei: an evaluation of salicylhydroxamic acid as a trypanocidal drug.
D000818:Animals; D001769:Blood / Q000469:parasitology; D004353:Drug Evaluation, Preclinical; D005260:Female; D006877:Hydroxamic Acids / Q000494:pharmacology / Q000627:therapeutic use / Q000633:toxicity; D008297:Male; D010101:Oxygen Consumption / Q000187:drug effects; D051381:Rats; D012457:Salicylamides / Q000494:pharmacology / Q000627:therapeutic use* / Q000633:toxicity; D014344:Trypanocidal Agents / Q000494:pharmacology / Q000627:therapeutic use* / Q000633:toxicity; D014346:Trypanosoma brucei brucei / Q000187:drug effects; D014352:Trypanosomiasis / Q000188:drug therapy* / Q000469:parasitology
D006877:Hydroxamic Acids; D012457:Salicylamides; D014344:Trypanocidal Agents; C005703:salicylhydroxamic acid